Form 8-K - Current report:
SEC Accession No. 0001104659-24-090546
Filing Date
2024-08-16
Accepted
2024-08-16 16:53:50
Documents
13
Period of Report
2024-08-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421627d3_8k.htm   iXBRL 8-K 30532
  Complete submission text file 0001104659-24-090546.txt   206289

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sgmt-20240815.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgmt-20240815_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgmt-20240815_pre.xml EX-101.PRE 22357
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2421627d3_8k_htm.xml XML 3815
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41742 | Film No.: 241217347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)